WJWilfredo E. De Jesus-Monge

Wilfredo E. De Jesus-Monge

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Wilfredo E. De Jesus-Monge has a total of 35 co-authors. Here are the top co-authors by number of shared publications:

  • Brian C. Lewis

    Program in Gene Function and Expression, University of Massachusetts Medical School, Worcester, Massachusetts 01605

    3 shared publications
  • David R. Driscoll

    Program in Gene Function and Expression, University of Massachusetts Medical School, Worcester, Massachusetts

    2 shared publications
  • David S. Klimstra

    Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York

    2 shared publications
  • Dulce M. Cruz-Oliver

    Division of Geriatric Medicine, Saint Louis University School of Medicine, 1402 S. Grand Blvd., M238, Saint Louis, MO, 63104, United States of America

    2 shared publications
  • Junhao Mao

    Department of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA

    2 shared publications
  • Mihir Rajurkar

    Department of Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA

    2 shared publications

Latest Publications

  • Experiences with End-of-Life Care in Paraguay

    by Dulce M. Cruz-Oliver, Wilfredo E. De Jesus-Monge, Miriam Rodin


  • Open Access

    Activated Wnt Signaling in Stroma Contributes to Development of Pancreatic Mucinous Cystic Neoplasms

    by Makoto Sano, David R. Driscoll, Wilfredo E. De Jesus-Monge, David S. Klimstra, Brian C. Lewis


  • The activity of Gli transcription factors is essential for Kras-induced pancreatic tumorigenesis

    by Mihir Rajurkar, Wilfredo E. De Jesus-Monge, David R. Driscoll, Victoria A. Appleman, He Huang, Jennifer L. Cotton, David S. Klimstra, Lihua J. Zhu, Karl Simin, Lan Xu, et al.

    Pancreatic ductal adenocarcinoma (PDAC), one of the most aggressive human malignancies, is thought to be initiated by KRAS activation. Here we find that transcriptional activation mediated by the Gli family of transcription factors, although dispensable for pancreatic development, is required for Kras-induced proliferation and survival in primary pancreatic epithelial cells in culture and for Kras-driven pancreatic intraepithelial neoplasia and PDAC formation in vivo. Further, ectopic Gli1 activation in the mouse pancreas accelerates Kras-driven tumor formation, underscoring the importance of Gli transcription factors in pancreatic tumorigenesis. Interestingly, we demonstrate Gli-regulated I-kappa-B kinase epsilon (IKBKE) and NF-κB activity in pancreatic cancer cells and show that this activity is a critical downstream mediator for Gli-dependent PDAC cell transformation and survival. Together, these studies demonstrate the requirement for Gli in Kras-dependent pancreatic epithelial transformation, suggest a mechanism of Gli-NF-κB oncogenic activation, and provide genetic evidence supporting the therapeutic targeting of Gli activity in pancreatic cancer.


  • The Requirement of GLI Transcriptional Activity in KRAS-Induced Pancreatic Neoplasia

    by Mihir Rajurkar, Wilfredo E. De Jesus-Monge, Brian C. Lewis, Junhao Mao

  • Mismatch repair protein expression and colorectal cancer in Hispanics from Puerto Rico

    by Wilfredo E. De Jesus-Monge, Carmen Gonzalez-Keelan, Ronghua Zhao, Stanley R. Hamilton, Miguel Rodriguez-Bigas, Marcia Cruz-Correa

    Colorectal cancer (CRC) is a leading cause of morbidity and mortality and alterations in mismatch repair (MMR) genes, leading to absent protein (negative) expression, are responsible for approximately 20% of CRC cases. Immunohistochemistry is a tool for prescreening of MMR protein expression in CRC but the literature on its use on Hispanics is scarce. However, Hispanics represent the second leading ethnicity in the United States (US) and CRC is a public health burden in this group. Our objectives were to determine the frequency of MMR protein-negative CRC and to evaluate its association with clinical and pathological characteristics among Hispanics from Puerto Rico, for the first time to our knowledge. A retrospective observational study of unselected CRC patients from the Puerto Rico Medical Center from 2001 to 2005 was done. MLH1 and MSH2, the most commonly altered MMR genes, protein expression was evaluated using immunohistochemistry, with microsatellite instability (MSI) and BRAF gene analyses in the absence of MLH1 protein expression. One-hundred sixty-four CRC patients were evaluated: the overall MMR protein-negative frequency was 4.3%, with 0.6% frequency of co-occurrence of MLH1-protein negative expression, MSI-high, and normal BRAF gene. MMR protein-negative expression was associated with proximal colon location (P = 0.02) and poor histological tumor differentiation (P = 0.001), but not with other characteristics. The frequency of MMR protein-negative CRC in Hispanics from Puerto Rico was lower than reported in other populations. This finding may explain the lower CRC incidence rate among US Hispanics as compared to US non-Hispanic whites and blacks.


  • Electronic Clinical Challenges and Images in GI

    by Wilfredo E. De Jesus-Monge

    • 1 January 2008
      • Vol. 18, S2-137

    Dysphagia and lung aspiration secondary to anterior cervical osteophytes: a case report and review of the literature.

    by Wilfredo E De Jesus-Monge, Elsie I Cruz-Cuevas

    Two of the most common causes of anterior cervical bony outgrowths are diffuse idiopathic skeletal hyperostosis (DISH) and ankylosing spondylitis (AS). These osteophytes have been associated with serious complications. The objective of this case report is to highlight how commonly occurring anterior cervical osteophytes may become an uncommon cause for life-threatening dysphagia and potential lung aspiration in elderly patients. An 80-year-old man came to the hospital with dyspnea and cough productive of sputum. These symptoms were associated with progressive dysphagia for the previous 10 years, which was evaluated with a barium esophagogram that was discontinued due to aspiration of barium. The patient was placed on mechanical ventilation. Neck computed tomography showed anterior cervical osteophytes displacing the upper airway and compressing the esophagus and calcification of the posterior longitudinal ligament with a "bamboo" appearance. The patient underwent surgical removal of the osteophytes. The patient had onset of symptoms at > 50 years of age, dysphagia, osteophytes in the clavicle and shoulders, anterior cervical osteophytes, calcified posterior longitudinal ligament, and spinal stenosis, all of which are associated with DISH. AS is associated with the patient's history of stooped posture, anterior displacement of the head while walking, and bamboo spine. The final diagnosis, either DISH or AS, causing these life-threatening anterior cervical osteophytes is undetermined because of the inability to evaluate for the respective diagnostic criteria. However, these osseous pathologies must be considered as causes of life-threatening dysphagia and aspiration in an elderly person.


    • 1 June 2004
      • Vol. 23, 61-7

    Response to combination therapy of interferon alfa-2b plus ribavirin in Hispanics with chronic hepatitis C.

    by Humberto Muñoz, Javier Arroyo, Esther A Torres, Wilfredo De Jesus-Monge, Betty Chinea, Henry González, Néstor Aponte, Aileen Guzmán, Cynthia Rivera, Federico Rodríguez, et al.

    To evaluate the response rate of Hispanics with chronic hepatitis C to combination therapy of interferon alfa-2b plus ribavirin and to assess its adverse events. Hepatitis C virus may lead to chronic infection and multiple complications. Response to combination therapy of interferon plus ribavirin has been studied in many populations. African Americans have been found to have a lower response rate than Caucasians. However, little data exist for Hispanics. Hispanic patients from Puerto Rico with chronic hepatitis C were eligible for the study between November 1997 and February 2000. The Institutional Review Boards of the participating institutions approved the study. Written informed consents were obtained. Combination therapy was given for 48 weeks and patients were followed for 24 weeks after treatment. Analysis of response to therapy was performed in an intention-to-treat basis. The most frequent adverse event was anemia (89%), associated to ribavirin. Sustained response was 23% for naive patients, 45% for relapsers, and 8% for non-responders to previous interferon monotherapy (p < 0.001). Data to analyze response was not available in 27% of patients. Hispanic patients had a low response rate to combination therapy. Response rates to combination therapy for Hispanic naive and previously non-responder patients are lower than in other reported populations. This may be due to a high prevalence of genotype 1 in Puerto Rico, which is associated to poor response. The higher response rate of relapsers, similar to those reported previously, was expected since these patients showed a previous response to interferon monotherapy. Ethnic factors may play a role in the response to therapy and should be further studied to determine proper treatment strategies for this population.